vs
Side-by-side financial comparison of Laird Superfood, Inc. (LSF) and SurgePays, Inc. (SURG). Click either name above to swap in a different company.
SurgePays, Inc. is the larger business by last-quarter revenue ($16.2M vs $13.3M, roughly 1.2× Laird Superfood, Inc.). Laird Superfood, Inc. runs the higher net margin — -13.2% vs -85.6%, a 72.5% gap on every dollar of revenue. On growth, SurgePays, Inc. posted the faster year-over-year revenue change (68.7% vs 15.0%). Over the past eight quarters, Laird Superfood, Inc.'s revenue compounded faster (16.1% CAGR vs -28.2%).
Laird Superfood, Inc. develops, manufactures and sells a portfolio of plant-based functional superfood products, including premium coffee creamers, hydration blends, nutritional supplements, and plant-powered snacks. It serves health-conscious consumers through direct-to-consumer e-commerce platforms and offline retail partners, mainly operating in the North American market with a focus on sustainably sourced clean ingredients.
SurgePays, Inc. is a U.S.-headquartered fintech and telecommunications company focused on serving underbanked and low-income communities across the country. It offers prepaid wireless plans, reloadable debit cards, digital banking solutions, and daily consumer products through a nationwide network of independent local retail partners such as convenience stores.
LSF vs SURG — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $13.3M | $16.2M |
| Net Profit | $-1.8M | $-13.9M |
| Gross Margin | 34.1% | -14.8% |
| Operating Margin | -13.5% | -79.1% |
| Net Margin | -13.2% | -85.6% |
| Revenue YoY | 15.0% | 68.7% |
| Net Profit YoY | -341.4% | 30.0% |
| EPS (diluted) | — | $-0.68 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $13.3M | $16.2M | ||
| Q3 25 | $12.9M | $18.7M | ||
| Q2 25 | $12.0M | $11.5M | ||
| Q1 25 | $11.7M | $10.6M | ||
| Q4 24 | $11.6M | $9.6M | ||
| Q3 24 | $11.8M | $4.8M | ||
| Q2 24 | $10.0M | $15.1M | ||
| Q1 24 | $9.9M | $31.4M |
| Q4 25 | $-1.8M | $-13.9M | ||
| Q3 25 | $-975.1K | $-7.5M | ||
| Q2 25 | $-362.2K | $-7.1M | ||
| Q1 25 | $-156.2K | $-7.6M | ||
| Q4 24 | $-398.4K | $-19.8M | ||
| Q3 24 | $-166.1K | $-14.3M | ||
| Q2 24 | $-239.1K | $-12.9M | ||
| Q1 24 | $-1.0M | $1.2M |
| Q4 25 | 34.1% | -14.8% | ||
| Q3 25 | 36.5% | -13.9% | ||
| Q2 25 | 39.9% | -23.0% | ||
| Q1 25 | 41.9% | -27.8% | ||
| Q4 24 | 38.6% | -117.0% | ||
| Q3 24 | 43.0% | -164.2% | ||
| Q2 24 | 41.8% | -22.8% | ||
| Q1 24 | 40.0% | 26.0% |
| Q4 25 | -13.5% | -79.1% | ||
| Q3 25 | -7.7% | -37.2% | ||
| Q2 25 | -3.3% | -59.1% | ||
| Q1 25 | -1.9% | -71.7% | ||
| Q4 24 | -4.1% | -209.0% | ||
| Q3 24 | -2.3% | -299.4% | ||
| Q2 24 | -3.4% | -72.1% | ||
| Q1 24 | -11.0% | 5.6% |
| Q4 25 | -13.2% | -85.6% | ||
| Q3 25 | -7.6% | -40.1% | ||
| Q2 25 | -3.0% | -61.5% | ||
| Q1 25 | -1.3% | -72.2% | ||
| Q4 24 | -3.4% | -206.5% | ||
| Q3 24 | -1.4% | -299.3% | ||
| Q2 24 | -2.4% | -85.3% | ||
| Q1 24 | -10.3% | 3.9% |
| Q4 25 | — | $-0.68 | ||
| Q3 25 | — | $-0.38 | ||
| Q2 25 | — | $-0.36 | ||
| Q1 25 | — | $-0.38 | ||
| Q4 24 | — | $-1.07 | ||
| Q3 24 | — | $-0.73 | ||
| Q2 24 | — | $-0.66 | ||
| Q1 24 | — | $0.07 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $5.1M | $1.7M |
| Total DebtLower is stronger | — | $13.3M |
| Stockholders' EquityBook value | $11.5M | $-15.3M |
| Total Assets | $19.2M | $8.5M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $5.1M | $1.7M | ||
| Q3 25 | $5.1M | $2.5M | ||
| Q2 25 | $3.9M | $4.4M | ||
| Q1 25 | $7.0M | $5.4M | ||
| Q4 24 | $8.3M | $11.8M | ||
| Q3 24 | $7.9M | $23.7M | ||
| Q2 24 | $7.6M | — | ||
| Q1 24 | $7.1M | — |
| Q4 25 | — | $13.3M | ||
| Q3 25 | — | $12.0M | ||
| Q2 25 | — | $9.6M | ||
| Q1 25 | — | $3.6M | ||
| Q4 24 | — | $4.0M | ||
| Q3 24 | — | $4.4M | ||
| Q2 24 | — | $4.8M | ||
| Q1 24 | — | $5.2M |
| Q4 25 | $11.5M | $-15.3M | ||
| Q3 25 | $12.8M | $-6.4M | ||
| Q2 25 | $13.4M | $116.1K | ||
| Q1 25 | $13.3M | $7.8M | ||
| Q4 24 | $13.2M | $15.3M | ||
| Q3 24 | $13.1M | $33.2M | ||
| Q2 24 | $12.6M | $46.2M | ||
| Q1 24 | $12.7M | $56.0M |
| Q4 25 | $19.2M | $8.5M | ||
| Q3 25 | $18.9M | $14.5M | ||
| Q2 25 | $20.4M | $15.2M | ||
| Q1 25 | $21.5M | $15.7M | ||
| Q4 24 | $19.3M | $24.0M | ||
| Q3 24 | $18.8M | $41.5M | ||
| Q2 24 | $18.0M | $56.4M | ||
| Q1 24 | $17.6M | $69.6M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 82.67× | ||
| Q1 25 | — | 0.46× | ||
| Q4 24 | — | 0.26× | ||
| Q3 24 | — | 0.13× | ||
| Q2 24 | — | 0.10× | ||
| Q1 24 | — | 0.09× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $68.4K | $-3.6M |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $68.4K | $-3.6M | ||
| Q3 25 | $1.2M | $-4.6M | ||
| Q2 25 | $-2.8M | $-6.1M | ||
| Q1 25 | $-1.3M | $-7.0M | ||
| Q4 24 | $339.2K | $-7.9M | ||
| Q3 24 | $305.8K | $-13.3M | ||
| Q2 24 | $642.7K | $-4.1M | ||
| Q1 24 | $-422.3K | $4.0M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | 3.30× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
LSF
| Wholesale | $7.0M | 52% |
| Coffee Tea And Hot Chocolate Products | $4.4M | 33% |
| Hydration And Beverage Enhancing Supplements | $1.6M | 12% |
| Other | $352.6K | 3% |
SURG
Segment breakdown not available.
